Last February, in a dimly lit room of the Vancouver Convention Centre, a group of researchers and university officials partook in a frenetic dance. The participants circled around a green plastic hoop and used only their little fingers to suspend the hoop in the air. The instructor then asked them to slowly lower the hoop to the ground.
Alas! Amid much screaming and shouting, the hoop rose remorsefully toward the ceiling. Why? Each little finger can exert influence only by pressing upward. Until the parties actually start talking to each other and figure out what is happening, the only place the hoop can go is up.
This group training exercise is a lighthearted component of a rapid-fire workshop on good research conduct run by the US Office of Research Integrity (ORI). The ORI-the largest office of its kind in the world-licenses misconduct procedures, supervises investigations, and promotes proper research conduct at more than 5,000 institutions worldwide that receive funding from the US Department of Health.
ORI was established in the aftermath of the infamous ''Baltimore case,'' when allegations of misconduct were filed against a junior staff member in David Baltimore's laboratory at the Massachusetts Institute of Technology. But, after the Congressional fireworks that attended this case faded, research conduct issues and the ORI itself retreated from public view.
In the past year, however, there has been an upsurge in global activity to address research misconduct. Scientists and editors are pushing universities and research agencies to take more responsibility for investigating and punishing misconduct. Canada has put new procedures in place to do this, and other nations are under pressure to follow suit.
Drip to Deluge?
Two main factors are likely driving this upsurge in official activity. One is the drip-drip-drip of high-profile misconduct cases. In 2005, Seoul National University unmasked the fraud by the Korean stem cell biologist, Hwang Woo-Suk, who had reported the successful production of human embryonic stem cells by cloning. Two years later, the Intergovernmental Panel on Climate Change erroneously reported false claims that all Himalayan glaciers would likely melt by 2035. Then, in 2010, the contentious research of Andrew Wakefield-which advocated a link between autism and the measles, mumps, and rubella vaccine-was discredited when the UK General Medical Council convicted him of misconduct and questioned the content of his papers.
A second factor is the flood of hard information regarding the frequency of misconduct. The caseload of the ORI has approximately doubled over the last decade, during which time the total number of retractions in scientific literature has risen tenfold, reaching 400 last year. The emerging subdiscipline of research into research integrity (RRI) has built up a body of evidence that ''serious misconduct,'' generally classified as ''falsification, fabrication, and plagiarism (FFP)'' is more frequent than these numbers suggest and that shaded forms of misconduct, such as redundant publication and the suppression of negative results, are much more common again.
Officials and universities struggle to outwrestle the potential rise in scientific misconduct. But what fraction of scientific misconduct cases do these numbers represent? ''It's tough to know if you're looking at the tip of the iceberg or the bottom of the iceberg,'' says Mark Frankel, director of scientific responsibility, human rights, and law at the American Association for the Advancement of Science (AAAS). However, the research in this field, the best of which relies on self-reporting questionnaires that researchers post anonymously, suggests that it is the tip of the iceberg.
According to a widely quoted 2009 metastudy by Daniele Fanelli of the University of Edinburgh, 2% of researchers confess to FFP, and as many as one-third confess to lesser forms of misconduct (Fanelli, 2009) . Fanelli, an evolutionary biologist who now studies research conduct, says the work has been surprisingly well received by other scientists. ''One of the things that has made misconduct less of a taboo is the fact that researchers are studying it, the same way that they would study anything else.'' These trends have shifted the way in which the issue is perceived by scientists. ''The community's approach has really changed,'' says Frankel. ''They were in denial for many years: but now, with twenty or thirty people being found guilty of misconduct each year, researchers realize that there is a problem.''
Minor Misconducts Forecast Fraud?
Around the world, a small cadre of university and government officials is charged with containing this problem. ORI is the global leader in this field; with a nine million dollar budget and a staff of 30, it requires annual certification from some 5,000 institutions worldwide. It also oversees their investigations, taking them on itself when necessary. But ORI's staff has slipped from 50 a decade ago, and it lacked a full-time director from 2009 until this January, when David Wright, a historian of science and former research integrity officer at Michigan State University, took on the role.
Wright says that there has been a shift during the past decade for ORI investigators to be more ''friendly and supportive'' toward the university integrity officers whose work they supervise. He says he wants its staff to work hand in hand with research institutions to strengthen both their investigations and their training programs.
But ORI's reach is limited to publicly funded health research; it has no jurisdiction over privately or foundation-funded research, even when most of this takes place in the same laboratories as NIH work. And its regime doesn't extend to other public funding agencies, who work by different rules. The National Science Foundation, for example, differs from ORI in that it doesn't publicly identify those who it finds guilty of misconduct.
Most importantly, federal agencies concern themselves with only the narrowest definition of research misconduct: FFP. That decision was made by the White House back in 2000, after scientific organizations successfully fought off recommendations of an independent commission, which was headed by Ken Ryan of Harvard University.
Ryan called for a broader definition of ''misconduct'' that included suppressing data and mistreating staff. But research organizations argued that FFP was fundamentally distinct from these lesser offenses.
The Woo-Suk case, however, appeared to vindicate Ryan's approach. Before Woo-Suk was accused of data fabrication, it was reported that he had used his laboratory assistants as sources for difficult-to-obtain human eggs-a serious accusation that senior colleagues regarded as incidental to his work (Cyranoski, 2004) . Only later did it emerge that he was fabricating data, too. His two main papers were retracted by Science in 2006 (Kennedy, 2006) .
That illustrated Ryan's basic point: if you're crassly exploiting female students, for example, the government probably shouldn't be paying for your work.
The United States has nonetheless stuck with the more narrow definition: falsification, fabrication, and plagiarism. But it is the only major power to do so. ''The US system is the oldest,'' observes Nicholas Steneck, a research integrity specialist at the University of Michigan, ''but I wouldn't call it the most advanced. What limits it is that its definition of misconduct is so narrow, and it is limited to government-funded research. '' In March, the US National Academy of Sciences convened a panel, chaired by Robert Nerem, a bioengineer at Georgia Tech, to revise Responsible Science, its landmark 1992 report on research integrity. The panel will report its findings in early 2013, and study director Tom Arrison says it will revisit the definition of misconduct. ''FFP is pretty directly in our task,'' Arrison says.
Canucks Take the Lead
One example for the Academy to consider is Canada's new Tri-Agency Framework on the Responsible Conduct of Research. The agency is backed by the three main government funding agencies, and it has a staff of eight to cover a research system one-tenth the size of that of the United States.
The responsibility of the agency is to oversee all research conducted at institutions that receive public funds. ''We use a much broader definition than FFP, and cover the breach of any ethics policy, and any mishandling of public funds,'' says Susan Zimmerman, the lawyer who directs the new secretariat in Ottawa.
Last December, Canada implemented comprehensive new arrangements to confront the rise in misconduct cases. Under the new rules, Zimmerman says, ''institutions have to have their own research conduct policy to cover all of their research, regardless of the source of funding.'' Canadian researchers who get public grants have to sign a consent form that will waive their privacy rights in the event of a ''serious breach'' of the Framework.
''This is an important innovation,'' Zimmerman says. ''There will be clear authority to publish names of anyone in breach of the rules.'' The new office expects to handle about 20 investigations in its first year, Zimmerman says.
Canada's shiny new system sounds rather like what the rest of the world would like but isn't going to get. At a stormy meeting in London this past January, for example, journal editors and senior scientists clashed angrily with university and British government officials, accusing the latter group of complacency in their handling of research misconduct.
This meeting was prompted by the failure of the University College London to investigate the Wakefield case (he was eventually investigated by the General Medical Council and barred from practicing medicine). The meeting ''got senior people to confront the issue, which some of them had not been doing,'' says Fiona Godlee, editor-in-chief of the British Medical Journal, which co-organized it with the Committee on Publication Ethics (COPE).
The meeting was galvanized by a strong statement from Michael Rawlins, chairman of the National Institute of Health and Clinical Excellence (NICE), which is the body that determines which drugs are paid for by Britain's National Health Service. He accused the universities and their funding bodies of complacency.
Afterward, he said that they are still downplaying the misconduct issue. ''There is a problem, both with fraudulent data and with the failure to publish negative results,'' he claims. ''In the world where I live, the results of clinical trials are very important. If there is fraud going on, people will be harmed. It is ultimately down to the universities. But either they don't think there is a problem, or they think that to touch it will damage their reputations. So they want to sweep it under the carpet.''
In a consensus statement published after the meeting, COPE called for far stronger mechanisms to deal with misconduct, including ''proper and secure financing'' for the UKRIO.
After the UK Department of Health withdrew financial support, that office is now surviving on a voluntary fee of £2,500 per year from universities, which only about half of the UK's main universities are paying. There have been ''various roadblocks'' to the agency's effective operation, which includes a lack of backing from the UK research councils, concedes Parry, the UKRIO's only fulltime staff member.
International Arms Race
Additional problems are raised by stark variation in how research integrity is perceived in different cultures. German courts, for example, have been reluctant to sanction the idea that a university or state agency can tell an individual researcher what to do.
Last August, the FASEB Journal retracted a 2003 paper by the German neuroscientist Nicolai Savaskan. The US journal had received a letter from Savaskan's university, the Charite Medical School in Berlin, stating that his paper contained ''gross flaws.'' Savaskan sued the university and won. That particular verdict was overturned on appeal in May.
Endocrinologist Volker Bä hr, who was appointed as Germany's first-ever research integrity officer at Charite last summer, says that the legacy of Nazism has left the courts generally inclined to place free expression above any institution's right to sanction scientists. ''As a consequence, it is often difficult to rectify scientific misconduct,'' Bä hr says.
Such international variations are now being investigated by the InterAcademy Council (IAC), which represents the national academies-the self-governing clubs of very senior scientists that ''speak for science'' around the world. The IAC's study into ''research integrity and scientific responsibility'' was prompted, in part, by the damage that the Himalayan glacier claim did to the global reputation of the whole IPCC, says Robbert Dijkgraff, a physicist and president of the Royal Netherlands Academy who also cochairs the IAC. ''Misconduct by one scientist in country X can undermine public confidence in country Y,'' he says. ''The thing we got worried about is where research happens in large international collaborations -so that the weakest link determines the outcome.''
The IAC panel will report this summer and hopes that its findings will help universities, agencies, and governments around the world to better manage research misconduct. The organization also plans to produce sets of training material by next year. Dijkgraff, who becomes director of the Institute for Advanced Studies in Princeton in July, thinks that better training holds the key. ''We don't teach our young people enough sense of the enormous responsibility that they have, or of the consequences of misconduct,'' he says.
The Internet, Photoshop, cutthroat competition, and even internationalism all lead pessimists to fear that research misconduct can only increase. At the same time, parts of the community are taking the problem seriously and are proactively pushing for more government action and funding to clamp down hard on it.
''There's broad recognition of the scope of the problem and agreement that it is underreported. It is being handled better, by and large,'' says Wright. ''But there are also more and more ways for people who want to cheat to do so-and lack of funding will induce more of them to try.'' The result, the ORI director notes, is a battle between two conflicting dynamics that isn't going to end anytime soon. ''It's like an arms race,'' he asserts.
